Leo Ruhnke

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

Peter Horak, Christoph Heining, Simon Kreutzfeldt et al. · Cancer Discovery · 2021 · 285 citations

Medicine, Molecular Genetics, Oncology +17

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

Arne Jahn, Andreas Rump, Thomas J. Widmann et al. · Annals of Oncology · 2022 · 80 citations · Full text

Medicine, Genetics, Oncology +17

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

Raphael Teipel, Frank Kroschinsky, Michael Krämer et al. · Blood Advances · 2022 · 56 citations · Full text

Life Sciences, Hematology, Immunology +15

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Jan‐Niklas Eckardt, Marius Bill, Christian Rausch et al. · Leukemia · 2023 · 36 citations · Full text

Life Sciences, Genetics, Oncology +14

The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia

Vladan Vučinić, Leo Ruhnke, Katja Sockel et al. · Blood Advances · 2021 · 23 citations · Full text

Medicine, Hematology, Oncology +14